MBXMBX Biosciences, Inc.

Healthcare
$53.26+433% 1Y

The financials

MBX Biosciences, Inc. by the numbers

The next results filing is expected around Nov 5, 2026, the same week as a year ago.

MBX Biosciences, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$41M−$22Mn/a
Net income−$37M−$19Mn/a
Diluted EPS−$0.78−$0.58n/a

Biotechnology

The closest names by size in the same industry

Compare peers
SLBT-1.3%
SL Science Holding Limited
PHVS+0.05%
Pharvaris N.V.
NRIX+0.68%
Nurix Therapeutics, Inc.
MLYS+4.4%
Mineralys Therapeutics, Inc.
BHVN+1.3%
Biohaven Ltd.
MRVI+3.7%
Maravai LifeSciences Holdings, Inc.